样式: 排序: IF: - GO 导出 标记为已读
-
Cardiac metastasis in uterine cervical cancer Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-17 I.-M. Simek, A. Sturdza, J. Knoth, A Spannbauer, J. Bergler-Klein, M. Vögele-Kadletz, J. Widder, M. P. Schmid
-
Comparison of liposomal gel with and without chamomile to prevent radiation dermatitis in breast cancer patients: a randomized controlled trial Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-12 Amanda Gomes de Meneses, Elaine Barros Ferreira, Larissa Aparecida Corrêa Vieira, Priscila de Souza Maggi Bontempo, Eliete Neves Silva Guerra, Marcia Aparecida Ciol, Paula Elaine Diniz dos Reis
-
The influence of different radiotherapy doses on the mechanical properties and microstructure of the enamel and dentin of human premolar teeth Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-16 Yuan Tu, Liying Hao, Yi Ding, Yisi Zhong, Chengge Hua, Li Jiang
-
Implementing stereotactic arrhythmia radioablation with STOPSTORM.eu consortium support: intermediate results of a prospective Israeli single-institutional trial Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-16 Egor Borzov, Roi Efraim, Mahmoud Suleiman, Raquel Bar-Deroma, Salem Billan, Jingyang Xie, Stephan Hohmann, Oliver Blanck, Tomer Charas
-
Nested CNN architecture for three-dimensional dose distribution prediction in tomotherapy for prostate cancer Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-16 Maryam Zamanian, Maziar Irannejad, Iraj Abedi, Mohsen Saeb, Mahnaz Roayaei
-
Analysis of operative duration of image-guided brachytherapy for cervical cancer Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-16 Yoshiaki Takagawa, Masanori Machida, Ichiro Seto, Shinya Komori, Hiroki Sato, Hiromitsu Endo, Hiroko Midorikawa, Takahiro Kato, Masao Murakami, Michitaka Honda, Koji Kono
-
Is intensive training with a time interval between instruction and planning CT necessary for deep inspiration breath-hold radiotherapy in breast cancer? Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-13 M. Sonnhoff, R.-M. Hermann, K. Aust, A.-C. Knöchelmann, M. Nitsche, B. Ernst, H. Christiansen, R.-M. Blach
-
Magnetic resonance imaging-based radiomics for predicting infiltration levels of CD68+ tumor-associated macrophages in glioblastomas Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-13 Qing Zhou, Bin Zhang, Caiqiang Xue, Jialiang Ren, Peng Zhang, Xiaoai Ke, Jiangwei Man, Junlin Zhou
-
Preclinical monitoring of radiation-induced brain injury via GluCEST MRI and resting-state fMRI at 7 T: an exploratory study on MRI-guided OAR avoidance Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-11 Guodong Li, Hao Li, Na Weng, Caiyun Liu, Xianglin Li, Qinglong Li, Li Bin, Kai Zhu, Danqi Huang, Jia Liu, Yan Liu, Xu Wang
-
Allies not enemies—creating a more empathetic and uplifting patient experience through technology and art Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-11 Luca Tagliaferri, Bruno Fionda, Calogero Casà, Patrizia Cornacchione, Sara Scalise, Silvia Chiesa, Elisa Marconi, Loredana Dinapoli, Beatrice Di Capua, Daniela Pia Rosaria Chieffo, Fabio Marazzi, Vincenzo Frascino, Giuseppe Ferdinando Colloca, Vincenzo Valentini, Francesco Miccichè, Maria Antonietta Gambacorta
-
Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-09 Qing Zhou, Xiaoai Ke, Jiangwei Man, Jian Jiang, Jialiang Ren, Caiqiang Xue, Bin Zhang, Peng Zhang, Jun Zhao, Junlin Zhou
-
Change in the serum selenium level of patients with non-metastatic and metastatic non-small cell lung cancer (NSCLC) during radiotherapy as a predictive factor for survival Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-06 Julia Ohlinger, Dirk Vordermark, Christian Ostheimer, Matthias Bache, Therese Tzschoppe, Kamil Demircan, Lutz Schomburg, Daniel Medenwald, Barbara Seliger
-
[Improving the nutritional situation of patients with advanced small cell lung cancer through off-label medication]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-05 Daphne Schepers-von Ohlen
-
Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-04 E. Hoffmann, A. Toepell, A. Peter, S. Böke, C. De-Colle, M. Steinle, M. Niyazi, C. Gani
-
[Pembrolizumab and radiochemotherapy in locally advanced cervical cancer-the prospective, randomised KEYNOTE-A18 phase 3 study]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-04 Maike Trommer,Aurélie Gaasch,Stefanie Corradini
-
Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome? Strahlenther Onkol. (IF 2.7) Pub Date : 2024-09-02 Sebastian N. Marschner, Cornelius Maihöfer, Richard Späth, Erik Haehl, Daniel Reitz, Nora Kienlechner, Lars Schüttrumpf, Philipp Baumeister, Ulrike Pflugradt, Julia Heß, Horst Zitzelsberger, Kristian Unger, Claus Belka, Franziska Walter
-
Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-30 Amelia Barcellini, Roberto Rordorf, Veronica Dusi, Giulia Fontana, Antonella Pepe, Alessandro Vai, Sandra Schirinzi, Viviana Vitolo, Ester Orlandi, Alessandra Greco
-
Robust IMPT and follow-up toxicity in skull base chordoma and chondrosarcoma—a single-institution clinical experience Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-29 Vesna Miladinovic, Yvonne L. B. Klaver, Augustinus D. G. Krol, Michiel Kroesen, Berit M. Verbist, Steven J. M. Habraken, Wouter R. van Furth, Ida E. M. Coremans
-
Artificial intelligence for response prediction and personalisation in radiation oncology Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-30 Alex Zwanenburg, Gareth Price, Steffen Löck
-
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO) Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-28 C. Zamboglou, D. M. Aebersold, C. Albrecht, D. Boehmer, U. Ganswindt, N.-S. Schmidt-Hegemann, S. Hoecht, T. Hölscher, S. A. Koerber, A.-C. Mueller, P. Niehoff, J. C. Peeken, M. Pinkawa, B. Polat, S. K. B. Spohn, F. Wolf, D. Zips, T. Wiegel
A significant number of prostate cancer patients are long-term survivors after primary definitive therapy, and the occurrence of late side effects, such as second primary cancers, has gained interest. The aim of this editorial is to discuss the most current evidence on second primary cancers based on six retrospective studies published in 2021–2024 using large data repositories not accounting for all
-
Multi-institutional analysis of extracranial oligometastatic colorectal cancer patients treated with stereotactic body radiation therapy: TROD 02-008 study Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-19 Ozan Cem Guler, Pervin Hurmuz, Banu Atalar, Yıldız Guney, Esra Kaytan Saglam, Serap Akyurek, Yasemin Bolukbasi, Zeynep Gural, Fuzuli Tugrul, Aylin Korcum, Cenk Ahmet Sen, Berna Akkus Yildirim, Didem Colpan Oksuz, Meral Kurt, Zeliha Guzeloz, Gorkem Aksu, Mert Saynak, Gamze Aksu, Cem Onal
-
Validation of the implementation of phased-array heating systems in Plan2Heat Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-14 H. P. Kok, J Crezee
-
Artificial intelligence for treatment delivery: image-guided radiotherapy Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-13 Moritz Rabe, Christopher Kurz, Adrian Thummerer, Guillaume Landry
-
Whole brain radiation therapy for patients with brain metastases: survival outcomes and prognostic factors in a contemporary institutional series Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-12 Anna Estermann, Chiara Schneider, Frank Zimmermann, Alexandros Papachristofilou, Tobias Finazzi
-
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-12 Nuo Yu, Xiankai Chen, Jiao Li, Xiaozheng Kang, Zhen Wang, Ruixiang Zhang, Jianjun Qin, Yong Li, Qingfeng Zheng, Guojie Feng, Lei Deng, Tao Zhang, Wenqing Wang, Wenyang Liu, Jianyang Wang, Qinfu Feng, Jima Lv, Zongmei Zhou, Zefen Xiao, Nan Bi, Yin Li, Xin Wang
-
Implementation of PET/CT in radiation oncology—a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-09 Simone Wegen, Ursula Nestle, Constantinos Zamboglou, Simon K. B. Spohn, Nils Henrik Nicolay, Lena M. Unterrainer, Stefan A. Koerber, Christian La Fougère, Emmanouil Fokas, Carsten Kobe, Chukwuka Eze, Anca-Ligia Grosu, Wolfgang P. Fendler, Adrien Holzgreve, Rudolf Werner, Nina-Sophie Schmidt-Hegemann
-
[Standard-of-care systemic therapy with or without SBRT in patients with oligoprogressive breast cancer or NSCLC (CURB oligoprogression): an open-label, randomised, controlled, phase 2 study]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-09 Florian Stritzke,Thomas Held
-
Outcome of intraoperative brachytherapy as a salvage treatment for locally recurrent rectal cancer Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-08 Raluca Stoian, Hannes P. Neeff, Mark Gainey, Michael Kollefrath, Simon Kirste, Constantinos Zamboglou, Jan Philipp Harald Exner, Dimos Baltas, Stefan Fichtner Feigl, Anca-Ligia Grosu, Tanja Sprave
-
Principles of artificial intelligence in radiooncology Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-06 Yixing Huang, Ahmed Gomaa, Daniel Höfler, Philipp Schubert, Udo Gaipl, Benjamin Frey, Rainer Fietkau, Christoph Bert, Florian Putz
-
Deep learning for autosegmentation for radiotherapy treatment planning: State-of-the-art and novel perspectives Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-06 Ayhan Can Erdur, Daniel Rusche, Daniel Scholz, Johannes Kiechle, Stefan Fischer, Óscar Llorián-Salvador, Josef A. Buchner, Mai Q. Nguyen, Lucas Etzel, Jonas Weidner, Marie-Christin Metz, Benedikt Wiestler, Julia Schnabel, Daniel Rueckert, Stephanie E. Combs, Jan C. Peeken
-
Long-term analysis of hematological parameters as predictors of recurrence patterns and treatment outcomes in cervical cancer patients undergoing definitive chemoradiotherapy Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-05 Aysenur Elmali, Ozan Cem Guler, Birhan Demirhan, Melek Yavuz, Cem Onal
-
Protocol-based CT-guided brachytherapy for patients with prostate cancer and previous rectal extirpation—a curative approach Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-02 Philipp Schubert, Vratislav Strnad, Thomas Weißmann, Claudia Schweizer, Michael Lotter, Stephan Kreppner, Andre Karius, Rainer Fietkau, Ricarda Merten
-
[Targeted therapy in EGFR-mutated lung cancer following chemoradiotherapy]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-02 Jörg Andreas Müller,Dirk Vordermark
-
Sarcopenia in glioblastoma: the imaging we need and what it tells us. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-02 Fabian M Troschel,Hans Theodor Eich
-
Sarcopenia in glioblastoma: pick up the probe and ditch the tomography. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-08-02 Ahmad J Abdulsalam,Murat Kara
-
Proton therapy reduces the effective dose to immune cells in breast cancer patients Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-25 Pierre Loap, Jeremi Vu-Bezin, Ludovic De Marzi, Youlia Kirova
-
[Postoperative radiotherapy for pT1-2N0 oral tongue carcinoma: time to reconsider?] Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-23 Justus Kaufmann,Heinz Schmidberger
-
[A 34-gene expression biomarker to predict oncologic outcome and treatment response after radiotherapy in meningioma]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-20 Maximilian Y Deng,Felix Sahm,Jürgen Debus,Laila König
-
[Systemic treatment with or without local ablative treatment of oligometastatic esophageal squamous cell carcinoma]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-19 Sophia Drabke,Justus Kaufmann,Heinz Schmidberger
-
[Cardiac irradiation for improvement of left ventricular function]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-17 Felix Mehrhof,Felix Hohendanner,Oliver Blanck,Gerhard Hindricks,Daniel Zips,Franziska Hausmann
-
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-12 Thomas B. Brunner, Judit Boda-Heggemann, Daniel Bürgy, Stefanie Corradini, Ute Karin Dieckmann, Ahmed Gawish, Sabine Gerum, Eleni Gkika, Maximilian Grohmann, Juliane Hörner-Rieber, Simon Kirste, Rainer J. Klement, Christos Moustakis, Ursula Nestle, Maximilian Niyazi, Alexander Rühle, Stephanie-Tanadini Lang, Peter Winkler, Brigitte Zurl, Andrea Wittig-Sauerwein, Oliver Blanck
-
Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy for triple-negative breast cancer in a patient with Bloom syndrome Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-12 Ali Fuat Gürbüz, Melek Karakurt Eryılmaz, Oğuzhan Yıldız, Fahriye Kılınç, Murat Araz, Mehmet Artaç
-
Effect of different optimization parameters in single isocenter multiple brain metastases radiosurgery Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-08 Angelika Altergot, Carsten Ohlmann, Frank Nüsken, Jan Palm, Markus Hecht, Yvonne Dzierma
-
Initial needle tracking with the first standalone combined infrared camera – CT system for brachytherapy—analysis of tracking accuracy and uncertainties Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-05 Andre Karius, Lisa Marie Leifeld, Vratislav Strnad, Claudia Schweizer, Rainer Fietkau, Christoph Bert
-
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report Strahlenther Onkol. (IF 2.7) Pub Date : 2024-07-02 Pierre Loap, Natacha Johnson, Rudy Birsen, Justine Decroocq, Youlia Kirova
-
Friedrich Dessauer (1881–1963): the forgotten medical physicist, politician, and philosopher Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-27 David Benzaquen, Daniel Taussky, Pierre-Alain Tercier, Ambroise Champion
Today, the name Friedrich Dessauer is almost forgotten; however, his scientific, social, and political works should not be. Dessauer’s professional career began at a young age as a professor of physics in Frankfurt am Main. It is said that he published 400 papers and 65 book chapters and pamphlets. He was a technical inventor who established laws that dealt with theories to explain the limited understanding
-
Impact of dose volume parameters and clinical characteristics on radiation-induced acute oral mucositis for head and neck cancer patients treated with carbon-ion radiotherapy dose volume outcome analysis Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-26 Yujiao Li, Xiyin Guan, Chaosu Hu
-
Timing of development of osteoradionecrosis post head and neck radiotherapy: does a safe time interval exist for dental extraction? Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-25 Petr Daniel Kovarik, Jakub Cvek, Rahul Patil, Craig Macdougall, Charles Kelly, Malcolm Jackson, Laura McKenzie, Nick West, Nicholas Willis, Josef Paul Kovarik, Muhammad Naveed Anwar, Islam Ellabban, Muhammad Shahid Iqbal
-
The effect of incidental dose to pelvic nodes in bladder-only irradiation in the era of IMRT: a dosimetric study Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-18 Gokhan Ozyigit, Alper Kahvecioglu, Mustafa Cengiz, Fazli Yagiz Yedekci, Pervin Hurmuz
-
Clinical and MRI risk factors predicting post-irradiation carotid blowout syndrome in patients with nasopharyngeal cancer Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-13 Ang Yang, Fei Duan, Ruo Lan Zao, Xue Hong Xiao, Ze Yan Wang
-
Regression of all untreated lesions in multifocal low-grade meningioma following fractionated stereotactic radiotherapy—abscopal effect or spontaneous regression? Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-13 Michael Pinkawa, Jan Boström, Susanne Temming, Andreas Schäfer, Attila Kovács, Azize Boström
-
Pulmonary artery intimal sarcoma: Case report of a patient managed with multimodality treatment and a comprehensive literature review Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-12 C. Atahan, Z. Güral, S. Yücel, F. Ağaoğlu
-
Cost-effectiveness analysis of bevacizumab for cerebral radiation necrosis treatment based on real-world utility value in China Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-03 Shaohong Luo, Shufei Lai, Yajing Wu, Jinsheng Hong, Dong Lin, Shen Lin, Xiaoting Huang, Xiongwei Xu, Xiuhua Weng
-
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost Strahlenther Onkol. (IF 2.7) Pub Date : 2024-06-03 Matthias Moll, Łukasz Magrowski, Martina Mittlböck, Harald Heinzl, Christian Kirisits, Jakub Ciepał, Oliwia Masri, Gerd Heilemann, Rafał Stando, Tomasz Krzysztofiak, Gabriela Depowska, Andrea d’Amico, Tomasz Techmański, Anna Kozub, Wojciech Majewski, Rafał Suwiński, Piotr Wojcieszek, Jacek Sadowski, Joachim Widder, Gregor Goldner, Marcin Miszczyk
-
Determinants of radiation dose to immune cells during breast radiotherapy Strahlenther Onkol. (IF 2.7) Pub Date : 2024-05-27 Pierre Loap, Jeremi Vu Bezin, Ludovic De Marzi, Youlia Kirova
-
[SBRT for primary kidney cancer: Data from the multicentre prospective FASTRACK II study]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-05-21 Janis Morgenthaler,Alexander Rühle,Simon Kirste,Maike Trommer
-
Reirradiation for diffuse intrinsic pontine glioma: prognostic radiomic factors at progression Strahlenther Onkol. (IF 2.7) Pub Date : 2024-05-15 Dominik Wawrzuta, Marzanna Chojnacka, Monika Drogosiewicz, Katarzyna Pędziwiatr, Bożenna Dembowska-Bagińska
-
Intraoperative radiation therapy for brain metastasis in a pregnant patient: a case report Strahlenther Onkol. (IF 2.7) Pub Date : 2024-05-15 K. P. Aninditha, S. Baumbach, T. Ellethy, G. Klumpp, A. Golle, S. Kuhn, N. Wegner, O. Ganslandt, M. W. Münter
-
[Validation of the genomic profile for personalized breast cancer treatment: POLAR study]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-05-14 Adrianna Monika Cieslak,Mathias Alexander Sonnhoff
-
[Less is not more, but just as good. Omitting axillary lymph node dissection is possible with adequate adjuvant therapy]. Strahlenther Onkol. (IF 2.7) Pub Date : 2024-05-14 Mathias Alexander Sonnhoff,Adrianna Monika Cieslak,David Krug